References
- Anon. Allergy: the unmet need. Royal College of Physicians (RCP), June 2003. Lavenham Press, Sudbury. Also available at www.rcplondon.ac.uk/pubs/books/allergy/allergy.pdf
- Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108:S2–8
- Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl): S147–334
- Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Int J Clin Pract 2004;58(2):109–18
- Ceuppens J. Western lifestyle, local defences and the rising incidence of allergic rhinitis. Acta Otorhinolaryngol Belg 2000;54:391–5
- Decision Resources Website – Patient Base section. Available from http://www.decisionresources.com/patientbase_2.asp [accessed 18 May 2005]
- Gold MS, Kemp AS. Atopic disease in childhood. Med J Aust 2005;182(6):298–304
- PRODIGY Guidance – Allergic Rhinitis, April 2002. Available from www.prodigy.nhs.uk/guidance.asp?gt=Allergic%20rhinitis [accessed 18 May 2005]
- Virant FS. Allergic rhinitis. Immunol Allergy Clin North Am 2000;20:265–82
- Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004;114(5 Suppl):S135–8
- Kremer B. Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol 2004;4(3):171–6
- Juniper EF, et al. Impact of upper respiratory allergic diseases on quality of life. J Allergy Clin Immunol, 1998; 108; S386–91
- Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hormann K, Maurer JT. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004;113(4): 663–8
- Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108:S45–53
- van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, Fokkens WJ, Howarth PH, Lund V, Malling HJ, Mygind N, Passali D, Scadding GK, Wang DY. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55(2):116–34
- Baroody FM. Allergic rhinitis: broader disease effects and implications for management. Otolaryngol Head Neck Surg 2003;128(5):616–31
- Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammee G for the XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004;114(4): 838–44
- Horak F, Ziegelmayer P, Ziegelmayer R, Kavina A, Lemell P. Levocetirizine has a longer duration of action on improving nasal symptoms than fexofenadine after single administration. In press, 2005
- Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol 2002;88(2):190–7
- Bloebaum RM, Grant JA. Levocetirizine: the allergist’s arsenal grows larger. Expert Opin Pharmacother 2004;5(7):1581–8
- Leurs R, Church MK, Taglialatela M. H1 antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Expl Allergy 2002;32: 489–98
- Molimard M, Diquet B, Benedetti MS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol 2004;18(4):399–411
- Day JH, Briscoe MP. Environmental exposure unit: a system to test anti-allergic treatment. Ann Allergy Asthma Immunol 1999;83(2):83–9
- De Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Paed Allergy Immunol. 2005;16(3):267–75
- De Blic J, Wahn U, Potter P. Levocetirizine for SAR and PAR in children. Poster presented at European Respiratory Society Congress, 2004, Glasgow, UK